Published on in Vol 8 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43292, first published .
Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation

Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation

Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation

Journals

  1. Hu P, Hu L, Wang F, Mei J. Editorial: Computing and artificial intelligence in digital therapeutics. Frontiers in Medicine 2024;10 View
  2. Johnson B, George J, Basanth A, Chandran V, Kesavadev J. The Plethora of Possibilities with a Smartphone in Diabetes Prevention and Care. International Journal of Diabetes and Technology 2023;2(4):123 View
  3. Ambesange A, Khomane A, Parikh J, Aswal D, Gharia M, Sharma P, Trivedi V, Maheshwari T, Mishra A, Bhavsar B, Athavale V. Optimizing glycemic control in type 2 diabetes: the impact of the GLIDE program’s personalized digital health intervention. Frontiers in Clinical Diabetes and Healthcare 2024;5 View
  4. Fassbender A, Donde S, Silva M, Friganovic A, Stievano A, Costa E, Winders T, van Vugt J. Adoption of Digital Therapeutics in Europe. Therapeutics and Clinical Risk Management 2024;Volume 20:939 View

Books/Policy Documents

  1. de Oliveira R, Oinas-Kukkonen H. Persuasive Technology. View